文献速递疝与腹壁外科胃肠外科

膈疝易感基因新发现:14个独立位点与遗传风险评分

Identification of 14 novel susceptibility loci for diaphragmatic hernia development and their biological and clinical implications: results from the UK Biobank.
PubMed 文献 · Surg Endosc · 2022-09-08

基于UK Biobank的两阶段全基因组关联研究,在36,351例膈疝患者中确认245个SNP达GWAS显著性,鉴定出14个独立易感位点。遗传风险评分在病例组显著升高并与膈疝风险增加相关,提示可用于术前风险分层与临床预测模型。

要点

  • 两阶段GWAS鉴定出14个与膈疝独立相关的易感位点。
  • 遗传风险评分在病例组显著高于对照组并与膈疝风险增加相关。
  • 部分位点与腹股沟疝已知位点重叠,提示共享遗传机制。

核心结论

  • 在UK Biobank大样本中鉴定出14个膈疝易感位点,共245个SNP达GWAS显著性。
  • 遗传风险评分与膈疝风险增加显著相关,可能用于术前风险分层和临床预测模型。

研究设计与样本

  • 基于UK Biobank的两阶段GWAS(发现与确认),发现阶段275,549人,确认阶段91,850人。
  • 发现阶段检测8,568,156个常染色体SNP(MAF>0.01),确认阶段验证P<1×10-5的SNP。
  • 共识别36,351例膈疝患者(ICD-10 K44),另在91,849人中计算遗传风险评分。

主要发现

  • 发现阶段2,654个SNP与膈疝相关(P<1×10-5),确认阶段338个SNP得到验证(P<0.05)。
  • 联合分析中245个SNP达GWAS显著性(P<5×10-8),LD clumping分析揭示14个独立位点。
  • 两个位点(2p16的rs181661155和11p13的rs5030123)既往与腹股沟疝相关。
  • eQTL分析提示CRLF1、UBA52和CALD1基因与这些位点显著相关。
  • 遗传风险评分在病例组较对照组显著升高(P<1×10-16),并与膈疝风险增加相关(P<1×10-7)。

临床怎么用

  • 遗传风险评分可能辅助术前识别膈疝高危患者,用于风险分层和临床预测模型。
  • 发现的易感位点及候选基因(CRLF1、UBA52、CALD1)为理解膈疝发病机制提供线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Genetic contributions to hernia development are incompletely understood. This study performed the first comprehensive genome-wide association study (GWAS) for diaphragmatic hernia using a large population-based cohort in the UK Biobank (UKB). METHODS AND PROCEDURES: Two-stage GWAS (discovery and confirmation) was performed for diaphragmatic hernia in the UKB. Briefly, 275,549 and 91,850 subjects were randomly selected for association tests in Stages 1 and 2, respectively. Association tests between 8,568,156 SNPs (genotyped or imputed with MAF > 0.01) in the autosomal genome and diaphragmatic hernia were performed in Stage 1. SNPs with P < 1 × 10-5 were selected for confirmation in Stage 2, and those with P < 0.05 and the same direction of association as Stage 1 were selected for combined association testing; SNPs with combined P < 5 × 10-8 were considered GWAS-significant. LD clumping analysis identified genetically independent chromosomal regions (loci). A genetic risk score (GRS) measured the cumulative risk of independent SNPs in 91,849 additional subjects using odds ratios (ORs) from Stages 1 and 2. RESULTS: 36,351 patients were identified with diaphragmatic hernia (ICD-10 K44). In Stage 1 analysis, 2654 SNPs were associated (P < 1 × 10-5) with diaphragmatic hernia. Stage 2 analysis confirmed 338 SNPs (P < 0.05). In combined analysis, 245 SNPs reached GWAS significance (P < 5 × 10-8). LD clumping analysis revealed 14 independent loci associated with diaphragmatic hernia. Two loci have been previously associated with inguinal hernia at 2p16 (rs181661155) and 11p13 (rs5030123). eQTL analysis suggested genes CRLF1, UBA52, and CALD1 are also significantly associated with these loci. GRS showed significant increase in cases compared to controls (P < 1 × 10-16) and is associated with increased risk of diaphragmatic hernia (P < 1 × 10-7). CONCLUSIONS: We identified 245 SNPs at 14 susceptibility loci associated with diaphragmatic hernia in a large population-based cohort. These results offer insight into pathogenetic mechanisms of diaphragmatic hernia development and may be used in genetic risk scores for pre-operative risk-stratification and clinical prediction models.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Campbell M, Wei J, Attaar M, et al. Identification of 14 novel susceptibility loci for diaphragmatic hernia development and their biological and clinical implications: results from the UK Biobank. Surg Endosc. 2022. PMID: 36076102. doi:10.1007/s00464-022-09064-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。